Insights
The pace of change has outrun the pace of understanding. Research, headlines, data, and expert opinion arrive faster than any team can absorb — and what was true last quarter keeps changing underneath you. You have information. What you need is healthcare industry insight.
Browse by category below,
or view the latest insights →
All insights
126 items
Conversations
We asked healthcare leaders what innovations they’re most excited about, here’s what they told us.
This fall we’ve been sitting down with healthcare experts from across the industry to talk to them about the future of innovation. Today I want to share with you our initial findings from those conversations, as well as a couple of insights about the state of healthcare innovation.
Kirsta Hackmeier
7 min read
Explainers
Drug shortages for the uninitiated
This month, my family and I were affected by two different drug shortages. First, we couldn’t fill a standing prescription for an ADHD drug that a child relies on to function at school. Then, we couldn't source a chemotherapy drug, causing a relative’s urgent cancer treatment to be delayed.
Amanda Berra
4 min read
Analysis
In praise of middle-ground strategy discussions
Why we developed the ‘Board Briefing’ series for members and the general public.
Amanda Berra & Yulan Egan
5 min read
Analysis
The real impact of the IRA drug price controls
Cost savings for seniors are real—but there are thousands of ways to squeeze the balloon.
Christopher Kerns
11 min read
Analysis
How to have meaningful conversations about innovation
Last month, we kicked off a new research study on the future of innovation. In the weeks that followed, we’ve had many fascinating conversations with industry leaders on the topic.
Kirsta Hackmeier
10 min read
Analysis
Healthcare 101: Dos and don’ts
A State of Healthcare keynote-style presentation is not a good fit for new healthcare learners—and a basic healthcare 101 might not be great either. Instead, consider a ‘market context for our organization’ (and not the solution I drafted first).
Amanda Berra
9 min read
Reports & slides
Union’s 2023 State of Healthcare—a first look at the report
At Union, we believe strongly in the power of a membership-based model—one that not only provides high-quality content, but also includes the personalized delivery of that content, access to experts, and opportunities to connect with industry peers.
Yulan Egan
11 min read
Analysis
Disruptive distributors—new entrants in the provider acquisition game
In April our CEO, Christopher Kerns, kicked off our series on vertical integration with a post on the state of healthcare consolidation—what it looks like today, the promise and perils heralded by supporters and detractors, and a reality check.
Kirsta Hackmeier
7 min read
Analysis
Are we approaching an MA profitability cliff?
For the better part of a decade now, the general industry view on Medicare Advantage has been one of overwhelming positivity. It’s been a steadily growing profit center for legacy plans and providers, and a relatively safe bet for newer market entrants and healthcare investors.
Yulan Egan
10 min read